Amicus (FOLD) Worth Up to $50/Sh in a Takeover, Chardan Says; Scioderm Deal Terms Suggest Future Sale
Tweet Send to a Friend
While not in their model, Chardan Capital Markets sees Amicus Therapeutics (NASDAQ: FOLD) worth $25-$50 in a takeover.Analyst Gbola Amus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
